Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 2
2003 3
2004 3
2005 3
2006 8
2007 9
2008 12
2009 13
2010 22
2011 13
2012 18
2013 23
2014 32
2015 38
2016 38
2017 43
2018 46
2019 54
2020 60
2021 77
2022 78
Text availability
Article attribute
Article type
Publication date

Search Results

534 results
Results by year
Filters applied: . Clear all
Page 1
Extensive germline genome engineering in pigs.
Yue Y, Xu W, Kan Y, Zhao HY, Zhou Y, Song X, Wu J, Xiong J, Goswami D, Yang M, Lamriben L, Xu M, Zhang Q, Luo Y, Guo J, Mao S, Jiao D, Nguyen TD, Li Z, Layer JV, Li M, Paragas V, Youd ME, Sun Z, Ding Y, Wang W, Dou H, Song L, Wang X, Le L, Fang X, George H, Anand R, Wang SY, Westlin WF, Güell M, Markmann J, Qin W, Gao Y, Wei HJ, Church GM, Yang L. Yue Y, et al. Among authors: fang x. Nat Biomed Eng. 2021 Feb;5(2):134-143. doi: 10.1038/s41551-020-00613-9. Epub 2020 Sep 21. Nat Biomed Eng. 2021. PMID: 32958897
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
Yang S, Li Y, Dai L, Wang J, He P, Li C, Fang X, Wang C, Zhao X, Huang E, Wu C, Zhong Z, Wang F, Duan X, Tian S, Wu L, Liu Y, Luo Y, Chen Z, Li F, Li J, Yu X, Ren H, Liu L, Meng S, Yan J, Hu Z, Gao L, Gao GF. Yang S, et al. Among authors: fang x. Lancet Infect Dis. 2021 Aug;21(8):1107-1119. doi: 10.1016/S1473-3099(21)00127-4. Epub 2021 Mar 24. Lancet Infect Dis. 2021. PMID: 33773111 Free PMC article. Clinical Trial.
Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial.
Zhang J, Hu Z, He J, Liao Y, Li Y, Pei R, Fang X, Zeng P, Fan R, Ou Z, Deng J, Zhou J, Guan W, Min Y, Deng F, Peng H, Zhang Z, Feng C, Xin B. Zhang J, et al. Among authors: fang x. Emerg Microbes Infect. 2021 Dec;10(1):1589-1597. doi: 10.1080/22221751.2021.1951126. Emerg Microbes Infect. 2021. PMID: 34197281 Free PMC article. Clinical Trial.
Cai LM, Fang X, Lin MJ, Xie J, Wang JD. Cai LM, et al. Among authors: fang x. Acta Crystallogr Sect E Struct Rep Online. 2012 May 1;68(Pt 5):o1351. doi: 10.1107/S1600536812013980. Epub 2012 Apr 13. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 22590246 Free PMC article.
Metabolic reprogramming in the arsenic carcinogenesis.
Ruan Y, Fang X, Guo T, Liu Y, Hu Y, Wang X, Hu Y, Gao L, Li Y, Pi J, Xu Y. Ruan Y, et al. Among authors: fang x. Ecotoxicol Environ Saf. 2022 Jan 1;229:113098. doi: 10.1016/j.ecoenv.2021.113098. Epub 2021 Dec 21. Ecotoxicol Environ Saf. 2022. PMID: 34952379 Free article. Review.
Primary cardiac angiosarcoma: a case report.
Fang X, Zheng S. Fang X, et al. J Int Med Res. 2021 Aug;49(8):3000605211033261. doi: 10.1177/03000605211033261. J Int Med Res. 2021. PMID: 34433329 Free PMC article.
Branching out.
Fang X, Chen XY. Fang X, et al. Sci China Life Sci. 2017 Jan;60(1):108-110. doi: 10.1007/s11427-016-0254-2. Epub 2016 Dec 19. Sci China Life Sci. 2017. PMID: 28000018 No abstract available.
Recent Advances on Bioactive Constituents in Ferula.
Zhou Y, Xin F, Zhang G, Qu H, Yang D, Han X. Zhou Y, et al. Among authors: xin f. Drug Dev Res. 2017 Nov;78(7):321-331. doi: 10.1002/ddr.21402. Epub 2017 Aug 8. Drug Dev Res. 2017. PMID: 28786182 Review.
534 results